Northern Virginia Oncology Group is a clinical research site located in Fairfax, Virginia, United States 22031.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Northern Virginia Oncology Group has participated in 4 clinical trials.
Therapeutic areas: Breast Neoplasms, Osteoporosis, Colorectal Neoplasms.
Sponsors: Novartis Pharmaceuticals, Novartis, Amgen.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Northern Virginia Oncology Group has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Northern Virginia Oncology Group has 4 clinical trials on record. Their work covers Breast Neoplasms, Osteoporosis, Colorectal Neoplasms.
Yes — Northern Virginia Oncology Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.